| Popis: |
In a response to my column,1 Hackett criticises the study by Finkle et al, which investigated about 55 000 men prescribed testosterone, considerably more than any previously published study assessing the cardiovascular risk of testosterone products.2 It found a significantly increased rate of non-fatal myocardial infarction in the three months after initial testosterone prescription compared with the previous year.3 Hackett challenges the validity of using non-fatal myocardial infarction as … |
